Skip to content

Clinical trials

Terminated Phase 2 Esophageal Squamous Cell Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 2 Status: Terminated Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20052
20061
20081
20111
20173
20181
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Oscar Lambret2
Peking University2
Alliance for Clinical Trials in Oncology1
BeiGene1
Boston Scientific Corporation1
Hebei Medical University Fourth Hospital1
Medstar Health Research Institute1
National Cancer Institute (NCI)1
Northwestern University1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma15
Esophageal Neoplasms7
Carcinoma, Squamous Cell2
Carcinoma, Non-Small-Cell Lung1
Melanoma1
Neoplasm Metastasis1
Neoplasms1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.